Corporate Liability from Employee Diversion: Costly on Many Fronts
FDA Law Blog
JUNE 22, 2022
This matter is the latest in a recent string of large monetary settlements between the government and health care providers involving employee diversion. The NPA requires “management” review of “any discrepancies discovered during an employee’s blind count when accessing controlled substances.”
52 
Let's personalize your content